Abstract
Calsequestrin Type 2 (CASQ2) is a high-capacity, low-affinity, Ca2+-binding protein expressed in the sarcoplasmic reticulum (SR) of the cardiac myocyte. Mutations in CASQ2 have been linked to the arrhythmia catecholaminergic polymorphic ventricular tachycardia (CPVT2) that occurs with acute emotional stress or exercise can result in sudden cardiac death (SCD). CASQ2G112+5X is a 16 bp (339–354) deletion CASQ2 mutation that prevents the protein expression due to premature stop codon. Understanding the subcellular mechanisms of CPVT2 is experimentally challenging because the occurrence of arrhythmia is rare. To obtain an insight into the characteristics of this rare disease, simulation studies using a local control stochastic computational model of the Guinea pig ventricular myocyte investigated how the mutant CASQ2s may be responsible for the development of an arrhythmogenic episode under the condition of β-adrenergic stimulation or in the slowing of heart rate afterward once β-adrenergic stimulation ceases. Adjustment of the computational model parameters based upon recent experiments explore the functional changes caused by the CASQ2 mutation. In the simulation studies under rapid pacing (6 Hz), electromechanically concordant cellular alternans appeared under β-adrenergic stimulation in the CPVT mutant but not in the wild-type nor in the non-β-stimulated mutant. Similarly, the simulations of accelerating pacing from slow to rapid and back to the slow pacing did not display alternans but did generate early afterdepolarizations (EADs) during the period of second slow pacing subsequent acceleration of rapid pacing.
Funder
National Institutes of Health
Subject
Genetics (clinical),Genetics
Reference74 articles.
1. Expanding spectrum of human RYR2-related disease: New electrocardiographic, structural and genetic features;Bhuiyan;Circulation,2007
2. Doste, R., and Bueno-Orovio, A. (2021). Multiscale Modelling of β-Adrenergic Stimulation in Cardiac Electromechanical Function. Mathematics, 9.
3. CPVT: Arrhythmogenesis, Therapeutic Management, and Future Perspectives. A Brief Review of the Literature;Baltogiannis;Front. Cardiovasc. Med.,2019
4. An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children with Catecholaminergic Polymorphic Ventricular Tachycardia;Peltenburg;Circulation,2022
5. Catecholaminergic-induced severe ventricular arrhythmia with Adams-Stokes syndrome in children: Report of four cases;Coumel;Br. Heart J.,1978
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献